The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain RCT Tested the Effect of TECAR Therapy on Sickle Cell Disease Chronic Pain.

Clinical trial NCT07066072 · COMPLETED

Trial details

NCT number: NCT07066072
Sponsor: Cairo University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

the Use of Radiofrequency Ablation in Form of TECAR(Capacitive and Resistive Transfer Energy) in Chronic Pain of Sickle Cell Disease Patients

Start date: 2022-12-01
Primary completion: 2025-01-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.